Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "RNA"

2994 News Found

SRM International Hand Conclave 2026 spotlights innovation and collaboration in hand rehabilitation
Healthcare | April 20, 2026

SRM International Hand Conclave 2026 spotlights innovation and collaboration in hand rehabilitation

The conclave brought together over 1,000 delegates from across India and internationally


Plasmidsaurus expands RNA-Seq in Europe, partners with Genovis for ambient RNA shipping
Biotech | April 10, 2026

Plasmidsaurus expands RNA-Seq in Europe, partners with Genovis for ambient RNA shipping

The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics


Bayer sets world record for maternal nutrition advocacy
Healthcare | April 09, 2026

Bayer sets world record for maternal nutrition advocacy

India continues to face a major maternal nutrition challenge, with nearly 60% of women affected by anaemia and more than 70% experiencing calcium deficiency


Moderna to reveal late-breaking data on flu & RSV mRNA vax at ESCMID 2026
Clinical Trials | April 08, 2026

Moderna to reveal late-breaking data on flu & RSV mRNA vax at ESCMID 2026

The data will be presented at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, April 17-21


MedGenome’s RNA-based NGS study sharpens sarcoma diagnosis, alters treatment in 25% cases
Biopharma | April 07, 2026

MedGenome’s RNA-based NGS study sharpens sarcoma diagnosis, alters treatment in 25% cases

India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases


VLCC becomes exclusive partner to offer international laser certification exams in India
News | April 01, 2026

VLCC becomes exclusive partner to offer international laser certification exams in India

This makes VLCC the sole institution in the country authorised to conduct in-person NCLC exams


BioNTech co-founders launch new mRNA venture, aiming to revolutionize next-gen therapies
News | March 14, 2026

BioNTech co-founders launch new mRNA venture, aiming to revolutionize next-gen therapies

The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission


Cirena licenses breakthrough RNA synthesis technology from CU Boulder
Biotech | March 11, 2026

Cirena licenses breakthrough RNA synthesis technology from CU Boulder

The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands


Moderna strikes $950 million global settlement with Arbutus & Genevant, clears legal hurdles for vaccine pipeline
News | March 05, 2026

Moderna strikes $950 million global settlement with Arbutus & Genevant, clears legal hurdles for vaccine pipeline

Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law